On Tuesday, 99% of the float of Nasdaq-listed medical technology company MiniMed Group Inc. was sold short, according to an estimate by data provider Ortex, up from 47.6% on September 15 and 77% a week earlier. This exceptional situation stems from a tax-free exchange offer by Medtronic, which owns 90% of MiniMed, offering 225.3 million MiniMed shares in exchange for Medtronic shares. Since MiniMed’s float holds only 28.5 million shares against 1.28 billion for Medtronic, arbitrageurs have been buying Medtronic shares while shorting nearly all available MiniMed shares to capture the arbitrage premium. The offer expires at midnight on Friday, explaining the urgency that drove short sellers to borrow and sell almost the entire MiniMed float.
Source: Read the original article


